 | • レポートコード：MRC309Z7986 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の粘膜下注射剤の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の粘膜下注射剤市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 粘膜下注射剤の成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 粘膜下注射剤市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・シリンジ式、アンプル式 用途別セグメント ・病院、外来手術センター、専門診療所 主要な市場プレーヤー ・Seikagaku、Ovesco Endoscopy、GI Supply、Cosmo Pharmaceuticals、Boston Scientific、The Standard、Micro-Tech Endoscopy、EndoClot Plus 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、粘膜下注射剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な粘膜下注射剤メーカーの企業概要、2019年～2022年までの粘膜下注射剤の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な粘膜下注射剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別粘膜下注射剤の販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの粘膜下注射剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での粘膜下注射剤市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および粘膜下注射剤の産業チェーンを掲載しています。 ・第14、15章では、粘膜下注射剤の販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 粘膜下注射剤の概要 - 種類別分析（2018年vs2022年vs2029年）：シリンジ式、アンプル式 - 用途別分析（2018年vs2022年vs2029年）：病院、外来手術センター、専門診療所 - 世界の粘膜下注射剤市場規模・予測 - 世界の粘膜下注射剤生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Seikagaku、Ovesco Endoscopy、GI Supply、Cosmo Pharmaceuticals、Boston Scientific、The Standard、Micro-Tech Endoscopy、EndoClot Plus ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：シリンジ式、アンプル式 ・用途別分析2018年-2029年：病院、外来手術センター、専門診療所 ・粘膜下注射剤の北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・粘膜下注射剤のヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・粘膜下注射剤のアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・粘膜下注射剤の南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・粘膜下注射剤の中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Submucosal Injection Agent market size was valued at USD 100.3 million in 2022 and is forecast to a readjusted size of USD 164.6 million by 2029 with a CAGR of 7.3% during review period.
Submucosal Injection Agent is a medical device that is an injectable liquid composition intended for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early stage cancers or other gastrointestinal mucosal lesions, prior to removal with a snare or endoscopic device.
It facilitates endoscopic resection procedures during endoscopic examinations in the upper and lower gastrointestinal tract, such as the esophagus, the stomach.
The global top five submucosal injection agent manufacturers include Seikagaku, Ovesco Endoscopy, GI Supply, Cosmo Pharmaceuticals, Boston Scientific, accounting for more than 60% of the market share, of which the largest manufacturer is Seikagaku, with a market share of more than 18%. North America is the most important submucosal injection agent consumer market in the world, with a market share of more than 32%. In terms of type, the market share of syringe type is more than 90%. In the application field, the market share of hospitals has reached more than 60%.
The Global Info Research report includes an overview of the development of the Submucosal Injection Agent industry chain, the market status of Hospitals (Syringe Type, Ampoule Type), Ambulatory Surgical Centers (Syringe Type, Ampoule Type), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Submucosal Injection Agent.
Regionally, the report analyzes the Submucosal Injection Agent markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Submucosal Injection Agent market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Submucosal Injection Agent market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Submucosal Injection Agent industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Syringe Type, Ampoule Type).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Submucosal Injection Agent market.
Regional Analysis: The report involves examining the Submucosal Injection Agent market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Submucosal Injection Agent market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Submucosal Injection Agent:
Company Analysis: Report covers individual Submucosal Injection Agent manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Submucosal Injection Agent This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Ambulatory Surgical Centers).
Technology Analysis: Report covers specific technologies relevant to Submucosal Injection Agent. It assesses the current state, advancements, and potential future developments in Submucosal Injection Agent areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Submucosal Injection Agent market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Submucosal Injection Agent market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Syringe Type
Ampoule Type
Market segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Major players covered
Seikagaku
Ovesco Endoscopy
GI Supply
Cosmo Pharmaceuticals
Boston Scientific
The Standard
Micro-Tech Endoscopy
EndoClot Plus
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Submucosal Injection Agent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Submucosal Injection Agent, with price, sales, revenue and global market share of Submucosal Injection Agent from 2018 to 2023.
Chapter 3, the Submucosal Injection Agent competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Submucosal Injection Agent breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Submucosal Injection Agent market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Submucosal Injection Agent.
Chapter 14 and 15, to describe Submucosal Injection Agent sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Submucosal Injection Agent
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Submucosal Injection Agent Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Syringe Type
1.3.3 Ampoule Type
1.4 Market Analysis by Application
1.4.1 Overview: Global Submucosal Injection Agent Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Centers
1.4.4 Specialty Clinics
1.5 Global Submucosal Injection Agent Market Size & Forecast
1.5.1 Global Submucosal Injection Agent Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Submucosal Injection Agent Sales Quantity (2018-2029)
1.5.3 Global Submucosal Injection Agent Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Seikagaku
2.1.1 Seikagaku Details
2.1.2 Seikagaku Major Business
2.1.3 Seikagaku Submucosal Injection Agent Product and Services
2.1.4 Seikagaku Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Seikagaku Recent Developments/Updates
2.2 Ovesco Endoscopy
2.2.1 Ovesco Endoscopy Details
2.2.2 Ovesco Endoscopy Major Business
2.2.3 Ovesco Endoscopy Submucosal Injection Agent Product and Services
2.2.4 Ovesco Endoscopy Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Ovesco Endoscopy Recent Developments/Updates
2.3 GI Supply
2.3.1 GI Supply Details
2.3.2 GI Supply Major Business
2.3.3 GI Supply Submucosal Injection Agent Product and Services
2.3.4 GI Supply Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GI Supply Recent Developments/Updates
2.4 Cosmo Pharmaceuticals
2.4.1 Cosmo Pharmaceuticals Details
2.4.2 Cosmo Pharmaceuticals Major Business
2.4.3 Cosmo Pharmaceuticals Submucosal Injection Agent Product and Services
2.4.4 Cosmo Pharmaceuticals Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Cosmo Pharmaceuticals Recent Developments/Updates
2.5 Boston Scientific
2.5.1 Boston Scientific Details
2.5.2 Boston Scientific Major Business
2.5.3 Boston Scientific Submucosal Injection Agent Product and Services
2.5.4 Boston Scientific Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Boston Scientific Recent Developments/Updates
2.6 The Standard
2.6.1 The Standard Details
2.6.2 The Standard Major Business
2.6.3 The Standard Submucosal Injection Agent Product and Services
2.6.4 The Standard Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 The Standard Recent Developments/Updates
2.7 Micro-Tech Endoscopy
2.7.1 Micro-Tech Endoscopy Details
2.7.2 Micro-Tech Endoscopy Major Business
2.7.3 Micro-Tech Endoscopy Submucosal Injection Agent Product and Services
2.7.4 Micro-Tech Endoscopy Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Micro-Tech Endoscopy Recent Developments/Updates
2.8 EndoClot Plus
2.8.1 EndoClot Plus Details
2.8.2 EndoClot Plus Major Business
2.8.3 EndoClot Plus Submucosal Injection Agent Product and Services
2.8.4 EndoClot Plus Submucosal Injection Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 EndoClot Plus Recent Developments/Updates
3 Competitive Environment: Submucosal Injection Agent by Manufacturer
3.1 Global Submucosal Injection Agent Sales Quantity by Manufacturer (2018-2023)
3.2 Global Submucosal Injection Agent Revenue by Manufacturer (2018-2023)
3.3 Global Submucosal Injection Agent Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Submucosal Injection Agent by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Submucosal Injection Agent Manufacturer Market Share in 2022
3.4.2 Top 6 Submucosal Injection Agent Manufacturer Market Share in 2022
3.5 Submucosal Injection Agent Market: Overall Company Footprint Analysis
3.5.1 Submucosal Injection Agent Market: Region Footprint
3.5.2 Submucosal Injection Agent Market: Company Product Type Footprint
3.5.3 Submucosal Injection Agent Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Submucosal Injection Agent Market Size by Region
4.1.1 Global Submucosal Injection Agent Sales Quantity by Region (2018-2029)
4.1.2 Global Submucosal Injection Agent Consumption Value by Region (2018-2029)
4.1.3 Global Submucosal Injection Agent Average Price by Region (2018-2029)
4.2 North America Submucosal Injection Agent Consumption Value (2018-2029)
4.3 Europe Submucosal Injection Agent Consumption Value (2018-2029)
4.4 Asia-Pacific Submucosal Injection Agent Consumption Value (2018-2029)
4.5 South America Submucosal Injection Agent Consumption Value (2018-2029)
4.6 Middle East and Africa Submucosal Injection Agent Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Submucosal Injection Agent Sales Quantity by Type (2018-2029)
5.2 Global Submucosal Injection Agent Consumption Value by Type (2018-2029)
5.3 Global Submucosal Injection Agent Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Submucosal Injection Agent Sales Quantity by Application (2018-2029)
6.2 Global Submucosal Injection Agent Consumption Value by Application (2018-2029)
6.3 Global Submucosal Injection Agent Average Price by Application (2018-2029)
7 North America
7.1 North America Submucosal Injection Agent Sales Quantity by Type (2018-2029)
7.2 North America Submucosal Injection Agent Sales Quantity by Application (2018-2029)
7.3 North America Submucosal Injection Agent Market Size by Country
7.3.1 North America Submucosal Injection Agent Sales Quantity by Country (2018-2029)
7.3.2 North America Submucosal Injection Agent Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Submucosal Injection Agent Sales Quantity by Type (2018-2029)
8.2 Europe Submucosal Injection Agent Sales Quantity by Application (2018-2029)
8.3 Europe Submucosal Injection Agent Market Size by Country
8.3.1 Europe Submucosal Injection Agent Sales Quantity by Country (2018-2029)
8.3.2 Europe Submucosal Injection Agent Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Submucosal Injection Agent Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Submucosal Injection Agent Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Submucosal Injection Agent Market Size by Region
9.3.1 Asia-Pacific Submucosal Injection Agent Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Submucosal Injection Agent Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Submucosal Injection Agent Sales Quantity by Type (2018-2029)
10.2 South America Submucosal Injection Agent Sales Quantity by Application (2018-2029)
10.3 South America Submucosal Injection Agent Market Size by Country
10.3.1 South America Submucosal Injection Agent Sales Quantity by Country (2018-2029)
10.3.2 South America Submucosal Injection Agent Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Submucosal Injection Agent Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Submucosal Injection Agent Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Submucosal Injection Agent Market Size by Country
11.3.1 Middle East & Africa Submucosal Injection Agent Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Submucosal Injection Agent Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Submucosal Injection Agent Market Drivers
12.2 Submucosal Injection Agent Market Restraints
12.3 Submucosal Injection Agent Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Submucosal Injection Agent and Key Manufacturers
13.2 Manufacturing Costs Percentage of Submucosal Injection Agent
13.3 Submucosal Injection Agent Production Process
13.4 Submucosal Injection Agent Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Submucosal Injection Agent Typical Distributors
14.3 Submucosal Injection Agent Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
